Bombay HC rules in favour of Natco Pharma
Bombay HC rules in favour of Natco Pharma and upholds earlier IPAB order. Bayer had challenged compulsory license granted to Natco Pharma.
Other Daily Videos
Budget 2024: ET Now explains key parameters you need to keep an eye on
IMF raises India's FY25 GDP growth forecast to 6.5%
Cross-hospital cashless treatment is a major move: New India Assurance CMD
Zee Ent moves NCLT after Sony terminates merger deal
ED conducts searches at Essel Group office in Mumbai, probes employees
